Justin Chow, MD
Internal Medicine · South Bend, INNPI 1700899622
Payments from drug & device makers
Across 69 payments — averaging $100.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$995
- Johnson & Johnson$906
- E.r. Squibb & Sons, L.L.C.$892
- AbbVie$493
- Boston Scientific$463
- Abbott$392
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,954100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 8 | $995 |
| Johnson & Johnson(2 entities) | 9 | $906 |
| E.r. Squibb & Sons, L.L.C. | 5 | $892 |
| AbbVie | 11 | $493 |
| Boston Scientific | 4 | $463 |
| Abbott | 3 | $392 |
| Sanofi | 3 | $310 |
| Novartis | 2 | $216 |
| Pharmacosmos Therapeutics Inc. | 2 | $213 |
| Grifols USA, LLC | 2 | $201 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $178 |
| W. L. Gore & Associates, Inc. | 1 | $153 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| Pharmaessentia USA Corporation | 1 | $125 |
| Abiomed | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $125 |
| GSK | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Incyte Corporation | 1 | $123 |
| Portola Pharmaceuticals, LLC | 1 | $123 |
| Beigene USA, Inc. | 1 | $118 |
| Bayer | 1 | $108 |
| Shockwave Medical, Inc | 1 | $101 |
| Exelixis Inc. | 1 | $99 |
| Amgen | 1 | $93 |
| Janssen Scientific Affairs, LLC | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$478
- LIBTAYO$238
- DARZALEX$222
- ENTRESTO$216
- GORE CARDIOFORM Septal Occluder$153
- WATCHMAN Access System$144
- AMPLATZER TALISMAN$134
- AMPLATZER AMULET$134
- Pomalyst$134
- General - Balloon Catheters$132
- Gamunex-C$129
- Venclexta$125
- ZEPZELCA$125
- BESREMI$125
- EPKINLY$125
- Reblozyl$125
- Impella$125
- Vascepa$125
- FARXIGA$125
- NUCALA$125
How this compares
$6,954 in reported general payments places this provider in the 90th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $9,193 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $507 |
| Ondansetron OdtOndansetron | 12 | $159 |
| Doxycycline Hyclate | 30 | $151 |
| Potassium Chloride | 13 | $96 |
| Metoprolol Succinate | 14 | $95 |
| Cefdinir | 14 | $82 |
| Prednisone | 20 | $66 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in South Bend
- Rita SchmidSouth Bend$599K
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.